Pulsatilla chinensis functions as a novel antihyperlipidemic agent by upregulating LDLR in an ERK-dependent manner
2024

Pulsatilla chinensis as a New Cholesterol-Lowering Agent

Sample size: 24 publication 10 minutes Evidence: moderate

Author Information

Author(s): Song Wei-fang, Wang Rui-jun, Yao Rui-xin, Jiang Qiu-yan, Feng Juan, Luo Kun, Di Zheng-han, Ma Cheng-mei

Primary Institution: Fenyang College, Shanxi Medical University

Hypothesis

Can Pulsatilla chinensis effectively lower cholesterol levels by upregulating LDLR through ERK signaling?

Conclusion

Pulsatilla chinensis acts as an antihypercholesterolemic agent by upregulating LDLR in an ERK-dependent manner.

Supporting Evidence

  • PC reduced serum total cholesterol and LDL cholesterol levels in hypercholesterolemic rats.
  • PC upregulated LDLR expression in HepG2 cells and rat livers.
  • PC treatment improved liver pathology in hypercholesterolemic rats.
  • PC was shown to activate ERK signaling, which is crucial for LDLR upregulation.

Takeaway

Pulsatilla chinensis is a plant that can help lower bad cholesterol in the body, making it good for heart health.

Methodology

The study involved high-throughput screening in HepG2 cells and in vivo evaluation in hypercholesterolemic rats, followed by transcriptome analysis and validation through RT-qPCR and western blot techniques.

Limitations

Pulsatilla chinensis is classified as a toxic TCM, necessitating further studies on its active components for safe administration.

Participant Demographics

Male Sprague–Dawley rats aged 6-8 weeks were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13020-024-01044-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication